Document is current
Any future updates will be listed below
-
Authors
Njoh, Journa
Abramowitz, Jonathan S.
Musci, Rashelle
Kimmel, Mary C.
Osborne, Lauren M.
Samuels, Jack
Nestadt, Paul
Nestadt, Gerald
Storch, Eric A.
-
Funding
Funding for this research was provided by:
The National Institute of Mental Health (R01MH118249)
The National Institute of Mental Health (R01MH118261)
National Institutes of Health (P50HD103555)
- License Information
-
More Information
Article History
Received: 16 December 2025
Accepted: 14 March 2026
First Online: 28 March 2026
Declarations
:
: The study protocol was approved by the UNC Institutional Review Board (IRB #19–1766) and was conducted in accordance with the ethical standards of the Declaration of Helsinki. Johns Hopkins University (IRB #IRB00212313) was reliant on the UNC IRB.
: Written informed consent was obtained from all individual participants included in the study.
: Not applicable. This manuscript does not contain any individual person’s identifiable data.
: Dr. Storch reports receiving research funding to his institution from the Ream Foundation, International OCD Foundation (IOCDF), and NIH. He was a consultant for Brainsway and Biohaven Pharmaceuticals in the past 24 months. He owns stock worth less than $5000 in NView (for distribution of the Y-BOCS and CY-BOCS; the Y-BOCS was used at no cost for this study). He provides training for the IOCDF where he receives compensation. He receives book royalties from Elsevier, Wiley, Oxford, American Psychological Association, J Guildford, Springer, and Routledge. Drs. Njoh, Abramowitz, P. Nestadt, G. Nestadt, Musci, Osborne, and Samuels have no disclosures to report.
